1 | Power of Attorney | 10 Sep 2005 |
10 | Forwarding Letter for TM-6 | 23 Jan 2009 |
11 | TM-6 | 30 Jan 2009 |
12 | Forwarding Letter for TM-6 | 11 Feb 2009 |
13 | TM-56 | 24 Mar 2009 |
14 | Order | 22 Dec 2010 |
15 | Hearing Notice | 24 Aug 2022 |
16 | Hearing Notice | 30 Dec 2022 |
17 | Hearing Notice | 14 Feb 2023 |
18 | Order | 22 Mar 2023 |
19 | Certificate | 23 Mar 2023 |
2 | Journal Copy | 06 Feb 2006 |
3 | Authorization Document (POA) | 10 Aug 2007 |
4 | TM-5 | 11 Nov 2008 |
5 | Forwarding Letter for TM-5 | 19 Nov 2008 |
6 | TM-44 | 16 Dec 2008 |
7 | TM-5 | 16 Dec 2008 |
8 | Forwarding Letter for TM-5 | 30 Dec 2008 |
9 | TM-6 | 05 Jan 2009 |
The application for Hycef was made on 06 February 2006.
The trademark applicant for Hycef is GRANDIX PHARMACEUTICALS.
Hycef is applied in class(es) 5.
Application for Hycef is on Registered stage.
Application Id allotted to Hycef is 1419291.
Trademark agent or attorney for the application is Apr Associates.
Hycef filed with the Intellectual property office as a WORD.